ATE513043T1 - Gegen denaturierungsmittel stabile und/oder proteaseresistente, chaperonähnliche oligomere proteine, diese kodierende polynukleotide sowie ihre verwendungen - Google Patents

Gegen denaturierungsmittel stabile und/oder proteaseresistente, chaperonähnliche oligomere proteine, diese kodierende polynukleotide sowie ihre verwendungen

Info

Publication number
ATE513043T1
ATE513043T1 AT02701532T AT02701532T ATE513043T1 AT E513043 T1 ATE513043 T1 AT E513043T1 AT 02701532 T AT02701532 T AT 02701532T AT 02701532 T AT02701532 T AT 02701532T AT E513043 T1 ATE513043 T1 AT E513043T1
Authority
AT
Austria
Prior art keywords
sps
chaperone
proteins
resistant
proteaser
Prior art date
Application number
AT02701532T
Other languages
English (en)
Inventor
Wangxia Wang
Dan Pelah
Tal Alegrand
Oded Shoseyov
Arie Altman
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE513043T1 publication Critical patent/ATE513043T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02701532T 2001-03-05 2002-03-05 Gegen denaturierungsmittel stabile und/oder proteaseresistente, chaperonähnliche oligomere proteine, diese kodierende polynukleotide sowie ihre verwendungen ATE513043T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27277101P 2001-03-05 2001-03-05
PCT/IL2002/000174 WO2002070647A2 (en) 2001-03-05 2002-03-05 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses

Publications (1)

Publication Number Publication Date
ATE513043T1 true ATE513043T1 (de) 2011-07-15

Family

ID=23041210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02701532T ATE513043T1 (de) 2001-03-05 2002-03-05 Gegen denaturierungsmittel stabile und/oder proteaseresistente, chaperonähnliche oligomere proteine, diese kodierende polynukleotide sowie ihre verwendungen

Country Status (8)

Country Link
US (1) US20050074763A1 (de)
EP (1) EP1481061B1 (de)
AT (1) ATE513043T1 (de)
AU (1) AU2002234863A1 (de)
CA (1) CA2440358C (de)
ES (1) ES2365602T3 (de)
IL (1) IL157766A0 (de)
WO (1) WO2002070647A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253341B2 (en) * 2001-03-05 2007-08-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
US20090253125A9 (en) * 2001-03-05 2009-10-08 Wangxia Wang Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
AR051866A1 (es) * 2004-12-24 2007-02-14 Cropdesign Nv Plantas con aumento del rendimiento y metodo de prepracion
CA2613619A1 (en) * 2005-07-07 2007-01-18 Fulcrum Sp Ltd. Sp1 polypeptides, modified sp1 polypeptides and uses thereof
EP2473520B1 (de) 2009-09-03 2015-09-30 Fulcrum S.P. Materials Ltd An mehreren stellen modifizierte polypeptide und ihre verwendung
US20110281256A1 (en) 2010-05-17 2011-11-17 Michael Glenn Davis Systems and Methods of Detecting and Demonstrating Hair Damage Via Evaluation of Protein Fragments
EP2714726B1 (de) * 2011-05-26 2017-01-04 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Biomolekulare elektronische vorrichtung und verwendungsverfahren
WO2014047453A2 (en) * 2012-09-20 2014-03-27 Novozymes A/S Screening polynucleotide libraries for variants that encode functional proteins
WO2014122654A2 (en) 2013-02-07 2014-08-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Hybrid nanopores and uses thereof for detection of analytes
WO2015116923A1 (en) 2014-01-31 2015-08-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
EP3194589B1 (de) 2014-07-31 2022-07-27 Primordial Genetics Inc. Zusammensetzungen zur verbesserung von zellen und organismen
IL243838A (en) 2016-01-28 2017-07-31 Sp Nano Ltd The composition containing sp1 protein and carbon nanoparticles and its uses
IL243839B (en) 2016-01-28 2018-01-31 Sp Nano Ltd Conductive wires
US11291721B2 (en) * 2016-03-21 2022-04-05 Marengo Therapeutics, Inc. Multispecific and multifunctional molecules and uses thereof
ES3063712T3 (en) 2017-05-15 2026-04-20 Cognition Therapeutics Inc Compositions for treating neurodegenerative diseases
US12247060B2 (en) 2018-01-09 2025-03-11 Marengo Therapeutics, Inc. Calreticulin binding constructs and engineered T cells for the treatment of diseases
EP3765517A1 (de) 2018-03-14 2021-01-20 Elstar Therapeutics, Inc. An calreticulin bindende multifunktionsmoleküle und ihre verwendungen
WO2020010250A2 (en) 2018-07-03 2020-01-09 Elstar Therapeutics, Inc. Anti-tcr antibody molecules and uses thereof
JP7579795B2 (ja) 2019-02-21 2024-11-08 マレンゴ・セラピューティクス，インコーポレーテッド ＮＫｐ３０に結合する抗体分子およびその使用
AU2020226893B2 (en) 2019-02-21 2025-02-27 Marengo Therapeutics, Inc. Multifunctional molecules that bind to T cell related cancer cells and uses thereof
US12352719B2 (en) 2019-09-20 2025-07-08 KYCERA AVX Components Corporation Somatic cell-based electrical biosensor
WO2021138474A2 (en) 2020-01-03 2021-07-08 Marengo Therapeutics, Inc. Anti-tcr antibody molecules and uses thereof
WO2026030341A1 (en) 2024-07-29 2026-02-05 Cognition Therapeutics, Inc. Zervimesine for treating neurodegenerative disease
WO2026136732A1 (en) 2024-12-18 2026-06-25 Cognition Therapeutics, Inc. Compositions and methods for the treatment of dementia with lewy bodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0748398A (ja) 1993-08-03 1995-02-21 Nippon Oil Co Ltd 変性蛋白質の再生方法及び変性蛋白質再生剤
JPH09173078A (ja) * 1995-09-14 1997-07-08 Tadayuki Imanaka 分子シャペロンを用いる蛋白質の製造方法

Also Published As

Publication number Publication date
EP1481061A4 (de) 2005-10-19
EP1481061B1 (de) 2011-06-15
IL157766A0 (en) 2004-03-28
US20050074763A1 (en) 2005-04-07
WO2002070647A3 (en) 2004-10-07
WO2002070647A8 (en) 2003-11-27
WO2002070647A2 (en) 2002-09-12
ES2365602T3 (es) 2011-10-07
CA2440358C (en) 2013-08-20
AU2002234863A1 (en) 2002-09-19
EP1481061A2 (de) 2004-12-01
CA2440358A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
WO2004022697A3 (en) Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
EP1481061A4 (de) Gegen denaturierungsmittel stabile und/oder proteaseresistente, chaperonähnliche oligomere proteine, diese kodierende polynukleotide sowie ihre verwendungen
DK1648931T3 (da) Multifunktionelle cytokiner
ATE510011T1 (de) Neue pilzproteine und diese codierende nukleinsäuren
ATE530643T1 (de) Säureaktive fungale protease
ATE446313T1 (de) Muteine von tränen-lipocalin
MY169472A (en) Refolding of recombinant proteins
WO2007110231A3 (en) MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
ATE517909T1 (de) Effizientes gewinnungsverfahren von korrekterweise rückgefalteten proteinen
ATE490968T1 (de) Schnell spaltbares sumofusionsprotein- expressionssystem für schwer zu exprimierende proteine
ATE430558T1 (de) Herstellung von mikrokügelchen
MX2008001865A (es) Proteinas de fusion de albumina.
ATE314480T1 (de) Fusionsproteine aus hirudin und proinsulin oder insulin
ATE469911T1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DK1255769T3 (da) Universel procedure til genfoldning af rekombinante proteiner
ATE293169T1 (de) Latency associated peptide von tgf-beta um pharmazeutisch aktive proteine latent zu machen
CY1112957T1 (el) Μη νευροτοξικοι παραγοντες, οι οποιοι ενεργοποιουν το πλασμινογονο για τη θεραπευτικη αγωγη εγκεφαλικου επεισοδιου
JP2018527030A5 (de)
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
WO2005078109A3 (en) Expression of plasminogen and microplasminogen in duckweed
AR053285A1 (es) Tratamiento de enfemedades usando un sistema mejorado de expresion regulada
KR20040053279A (ko) 스트레스 저항성 및 내성 단백질을 코딩하는 유전자
ATE447008T1 (de) Rre und cte umfassende gentechnische konstrukte und zusammensetzungen und verwendungen davon
DK1639110T3 (da) Rajgræspollenspecifikke promotorer og ekspressionskonstructer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties